breast cancer

Open Access
[¹¹C]Methionine PET vs. [¹⁸F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients
MOTOKAZU SATO, TOSHIHIKO SATO, CHIHIRO HOZUMI, QINGHONG HAN, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN

Anticancer Research September 2024, 44 (9) 3891-3898; DOI: https://doi.org/10.21873/anticanres.17216
You have access
Sequential Moderate Hypofractionated Boost in Breast Cancer Patients: A Monoinstitutional Analysis of Late Side Effects
ISABELLA PALUMBO, ANNA GIULIA BECCHETTI, ELISABETTA PERRUCCI, LORENZO FALCINELLI, SIMONETTA SALDI, VITTORIO BINI and CYNTHIA ARISTEI

Anticancer Research September 2024, 44 (9) 3965-3971; DOI: https://doi.org/10.21873/anticanres.17225
You have access
Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing
HYUNWOO LEE, YOON AH CHO, DEOK GEUN KIM, JAE YOUNG SON and EUN YOON CHO

Anticancer Research September 2024, 44 (9) 3983-3994; DOI: https://doi.org/10.21873/anticanres.17227
You have access
Postoperative Radiotherapy Using VMAT for RNI Including IMN in Breast Cancer: Report of Short-term Follow-up
TOMOAKI YANO, YUKA ONO, MICHIO YOSHIMURA, TOMOHIRO ONO, MAKOTO SASAKI, TAKAHIRO FUJIMOTO and TAKASHI MIZOWAKI

Anticancer Research September 2024, 44 (9) 4011-4018; DOI: https://doi.org/10.21873/anticanres.17230
You have access
Prognostic Impact of Human Lymphocyte Antigen (HLA) Class I Expression in Patients With Breast Cancer
MOTONOBU UCHIYAMA, HIROAKI SHIMA, GORO KUTOMI, DAISUKE KYUNO, ASAKA WADA, YOKO KUGA, YASUAKI TAMURA, YOSHIHIKO HIROHASHI, TOSHIHIKO TORIGOE and ICHIRO TAKEMASA

Anticancer Research September 2024, 44 (9) 4039-4047; DOI: https://doi.org/10.21873/anticanres.17233
Open Access
Unveiling the Complex Ecosystem of Breast Cancer: Crucial Insights for Patients and Doctors
KEFAH MOKBEL

Anticancer Research August 2024, 44 (8) 3317-3319; DOI: https://doi.org/10.21873/anticanres.17150
You have access
Oestrogen Represses Noggin Expression by Interfering With BMP/Smad Signalling in ER Positive Breast Cancer
MING LIU, DEBBY KOO, WEN G. JIANG and LIN YE

Anticancer Research August 2024, 44 (8) 3355-3364; DOI: https://doi.org/10.21873/anticanres.17156
You have access
Risk Factors for Non-sentinel Lymph Node Metastasis in HR+/HER2− Breast Cancer With cN0
YONG MIN NA, SANG CHUN PARK, YOUNG JAE RYU, JIN SEONG CHO and MIN HO PARK

Anticancer Research August 2024, 44 (8) 3493-3500; DOI: https://doi.org/10.21873/anticanres.17169
You have access
Neoadjuvant Versus Adjuvant Systemic Therapy in Breast Cancer: A Matched Case-control Study
MARA CAROPRESE, MANUEL CONSON, ANGELA BARILLARO, CHIARA FEOLI, LAURA CELLA, CATERINA OLIVIERO, STEFANIA CLEMENTE, ANTONIO FARELLA, CARMINE DE ANGELIS, MARIO GIULIANO, GRAZIA ARPINO, STEFANIA SCALA and ROBERTO PACELLI

Anticancer Research August 2024, 44 (8) 3501-3506; DOI: https://doi.org/10.21873/anticanres.17170
You have access
Clinical Diagnostic Value of circ-ARHGER28 for Breast Cancer and its Effect on MCF 7 Cell Proliferation and Apoptosis
XIANG TAO, LI NA, EN-XI HU, JIA WANG, LI-GANG WU, XU ZHANG and LI-BIN WANG

Anticancer Research July 2024, 44 (7) 2877-2886; DOI: https://doi.org/10.21873/anticanres.17100

Main menu

User menu

Search

breast cancer

Pages